Having supported more than 250 global medical device studies to date, Clinlogix delivers outstanding performance in today’s global development environment. Experience is an unparalleled asset in this space, which is why we have medical device validation, clinical operations, and data management experts on staff, along with access to a vast network of influential medical and scientific advisors.

For these reasons, every top 10 medical device development company and a growing number of midsized businesses have partnered with Clinlogix.

With experience in all device classes — particularly in classes II and III — and first-in-human studies, we can execute global, full-service clinical trial conduct at any scale. Internally, we have a global SOP (90+) system that is ISO 9001:2015 certified, and we maintain close partnerships with leading eClinical, imaging, logistics, and translation vendors to ensure quality research conduct and product handling from start to finish.

Minimally Invasive Technologies

  • AV fistula access devices
  • Carotid and renal stents
  • Coronary and peripheral stents (bare and drug-eluting)
  • Coronary drug-eluting scaffolds
  • Drug-coated or drug-eluting balloons
  • Peripheral and endovascular stents (superficial femoral artery (SFA), coated)
  • Stent grafts (aortic and abdominal)
  • Wound closure

Acute Coronary Syndrome (ACS)

  • Acute myocardial infarction
  • Aortic and mitral valves (repair and replacement)
  • Structural heart
  • Unstable angina ST-elevation myocardial infarction (STEMI) and non-STEMI

Heart Failure

  • Acute heart failure
  • Atherectomy and thrombectomy
  • Atrial fibrillation
  • Carotid denervation
  • Congestive heart failure
  • Left ventricular heart failure
  • Pain management
  • Percutaneous transluminal coronary angioplasty (PTCA) and stent implantation in high-risk patients: left ventricular support
  • Renal denervation
  • Robotics
  • Stroke prevention

Diabetes

  • Blood glucose meters (BGMs)
  • Continuous glucose monitors (CGM)
  • Heating devices
  • Non-invasive glucose monitoring devices
  • Pens

250 Global Studies

2425 Clinical Sites

1 Team

New ideas pose new challenges. If you’re developing a new treatment or technology, you need a partner that can navigate unexplored territory while still ensuring efficient research conduct and comprehensive regulatory strategies. That is exactly what Clinlogix delivers. Our global access to key opinion leaders and best-in-class clinical sites ensures top performing sites can successfully bring your program across the finish line.